Children's self-reports on perceived effects on taking stimulant medication for ADHD

Journal of Attention Disorders

Volumn 12, Issue 5, 2009, Pages 460-468

  Thorell, Lisa B ^a   Dahlstrm, Kerstin ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

ADHD; Effects; Self report; Stimulant treatment

Indexed keywords

AMPHETAMINE; CENTRAL STIMULANT AGENT; METHYLPHENIDATE;

ACHIEVEMENT; ADOLESCENT; AGGRESSION; ARTICLE; ATTENTION DEFICIT DISORDER; ATTITUDE TO HEALTH; AWARENESS; CHILD; DRUG EFFECT; FEMALE; HUMAN; MALE; MOTIVATION; PATIENT SATISFACTION; PERSONALITY TEST; PSYCHOLOGICAL ASPECT; PSYCHOMETRY; QUESTIONNAIRE; SOCIAL BEHAVIOR; SOCIAL ENVIRONMENT; STATISTICS; SWEDEN;

ACHIEVEMENT; ADOLESCENT; AGGRESSION; AMPHETAMINE; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; ATTITUDE TO HEALTH; AWARENESS; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; FEMALE; HUMANS; MALE; METHYLPHENIDATE; MOTIVATION; PATIENT SATISFACTION; PERSONALITY ASSESSMENT; PSYCHOMETRICS; QUESTIONNAIRES; SOCIAL BEHAVIOR; SOCIAL ENVIRONMENT; SWEDEN;

EID: 60449120684     PISSN: 10870547     EISSN: None     Source Type: Journal    
DOI: 10.1177/1087054708320430     Document Type: Article

References (21)

1. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4 th ed.). Washington, DC: Author.
2. Barkley, R.A. (1977). A review of stimulant drug research with hyperactive children. Journal of Child Psychology and Psychiatry, 18, 137-165.
3. Borgschatz, H., Frankenberger, W., & Eder, R. (1999). Effects of information on perceptions of stimulant medication efficacy for treatment of attention-deficit hyperactivity disorder. Psychology in the Schools, 36, 515-522.
4. Bowen, J., Fenton, T., & Rappaport, L. (1991). Stimulant medication and attention deficit-hyperactivity disorder: The child's perspective. Journal of Diseases of Children, 145, 291-295.
5. Brown, T.E. (2000). Attention-deficit disorders and comorbidities in children, adolescents and adults. Washington, DC: American Psychiatric Press.
6. Conners, C.K. (1971). Recent drug studies with hyperkinetic children. Journal of Learning Disabilities, 4, 476-483.
7. Conners, C.K. (1973). Rating scales for use in drug studies with children. Psychopharmacology Bulletin, 9, 24-84.
8. Doherty, S.L., Frankenberger, W., Fuhrer, R., & Snider, V. (2000). Children's self-reported effects of stimulant medication. International Journal of Disability, Development, and Education, 47, 39-54.
9. Douglas, V.I. (1972). Stop, look, and listen: The problem of sustained attention and impulse control in hyperactive and normal children. Canadian Journal of Behavioral Science, 4, 259-282.
10. Fitzpatrick, P.A., Klorman, R., Brumaghim, J.T., & Borgstedt, A.D. (1992). Effects of sustained-release and standard preparations of methylphenidate on attention deficit disorder. Journal of American Academy of Child and Adolescent Psychiatry, 31, 226-234.
11. Flanery, R. (1990). Methodological and psychometric considerations in child reports. In A. M. La Greca (Eds.), Through the eyes of the child: Obtaining self-reports from children and adolescents (pp. 57-82). Boston: Allyn & Bacon.
12. Kazdin, A. (1990). Assessment of childhood depression. In A. M. La Greca (Eds.), Through the eyes of the child: Obtaining self-reports from children and adolescents (pp. 189-233). Boston: Allyn & Bacon.
13. Kazdin, A., Rodgers, A., Colbus, D., & Siegel, T. (1987). Children's Hostility Inventory: Measurement of aggression and hostility in psychiatric inpatient children. Journal of Clinical Child Psychology, 16, 320-328.
14. Moline, S., & Frankenberger, W. (2001). Use of stimulant medication for treatment of attention-deficit/hyperactivity disorder: A survey of middle and high school students' attitudes. Psychology in the Schools, 38, 569-584.
15. MTA Cooperative Group. (1999). A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Archives of General Psychiatry, 56, 1073-1086.
16. Muir, T., & Zegarac, M. (2001). Societal costs of toxic substances: Economic and health costs of four case studies that are candidates for environmental causation. Environmental Health Perspective, 109 (Suppl. 6). 885-903.
17. Muris, P., Vaesen, H., Roodenrijs, D., & Kelgterman, L. (2006). Treatment sensitivity for a brief rating scale for attention-deficit hyperactivity disorder (ADHD) symptoms. Journal of Child and Family Studies, 15, 223-230.
18. National Institutes of Health. (1998, November). Consensus development conference statement: Diagnosis and treatment of attention-deficit/hyperactivity disorder. Bethesda, MD: Author.
19. Swanson, J.M., McBurnett, K., Wigal, T., Pfiffner, L., Lerner, M., Williams, L., et al. (1993). Effect of stimulant medication on children with attention deficit disorder: A "review of reviews." Exceptional Children, 60, 154-161.
20. Swedish National Board of Health and Welfare. (2002). ADHD hos barn och vuxna [ADHD among children and adults]. Stockholm, Sweden: Socialstyrelsen.
21. U.S. Drug Enforcement Agency. (1999). Yearly aggregate production quotas (1990-1999). Washington, DC: Author.